Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Deutsche Medizinische Wochenschrift (1946)|October 5, 2016
[Update on pericardial diseases]Joachim Seichter, Bernhard Schieffer
Frontiers in Cardiovascular Medicine|October 3, 2022
The rationale for the treatment of long-Covid symptoms - A cardiologist's viewElisabeth Schieffer, Bernhard Schieffer
Trends in Cardiovascular Medicine|August 21, 2012
Emerging role of chemokine receptor 7 in atherosclerosisBernhard Schieffer, Maren Luchtefeld
Frontiers in Cardiovascular Medicine|August 7, 2023
Corrigendum: The rationale for the treatment of long-COVID esymptoms-a cardiologist's viewElisabeth Schieffer, Bernhard Schieffer
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 10, 2022
The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 InfectionElisabeth Schieffer, Bernhard Schieffer
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Therapeutic effects of angiotensin (AT1) receptor antagonists: potential contribution of mechanisms other than AT1 receptor blockadeBoris Schmidt, Helmut Drexler, Bernhard Schieffer
Biochemical and Biophysical Research Communications|August 14, 2003
5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activationMaren Luchtefeld, Helmut Drexler, Bernhard Schieffer
Pageof 19